Generalized Anxiety Disorder 7-item
The GAD-7 is a brief self-report screen of anxiety symptom frequency over the past two weeks. This page explains the measure for clinics. It is not a test to complete here.
Overview
What is the GAD-7?
The Generalized Anxiety Disorder 7-item scale was developed by Spitzer, Kroenke, Williams and colleagues as a short self-report measure of anxiety symptom burden. Clinics use it for intake, review, and monitoring. It does not by itself establish an anxiety disorder diagnosis.
Development and clinical use
GAD-7 was introduced in the mid-2000s with a Pfizer educational grant and later became one of the most widely used brief anxiety measures in primary care and specialist services. The source form states that no permission is required to reproduce, translate, display, or distribute.
- Source instrument
- 7 self-report items
- Reference period
- Past 2 weeks
- Response format
- 4 frequency options
- Respondent
- Patient self-report
- Typical use
- Screening and monitoring
- Clinical role
- Screening support
Administration
A focused client experience
Respondents rate how often seven problems have bothered them over the past two weeks. Results are intended to support a clinician conversation about symptom burden, duration, impairment, and whether a fuller anxiety assessment is needed.
- One question at a time with visible progress
- Large keyboard-operable response choices
- Previous, next, and answer-review steps
- Clear confirmation that results go to the clinic
Frequency choices are shown without reproducing GAD-7 item wording.
Report showcase
Designed to make evidence easy to review
Lirena's public pages show how response evidence would be laid out for a responsible clinician. This illustration uses no patient data and does not reproduce instrument questions.
- Named instrument, version, and provenance
- Item-level response pattern without source wording
- Methodology, references, and clinical boundary
- Responsible clinician review rather than automated conclusions
Clinician review required
Methodology
Understand the measure and its scoring conventions
Published source materials describe a 0-21 total and suggested screening bands. This public page does not independently verify scoring, cutoffs, or a production scoring rule. Use the official form and scoring instructions for the version you intend to use.
References
- Original GAD-7 validationSpitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder. Arch Intern Med. 2006;166(10):1092-1097.
- Official source formsPfizer Inc. Patient Health Questionnaire (PHQ) screeners.
Questions
What clinics ask before they evaluate the GAD-7
These answers stay inside educational catalogue scope. They do not replace official manuals, licences, or clinician judgement.
What is the GAD-7 used for?
Clinics use it as a short anxiety symptom screen and a way to track change. It structures how often the person has been bothered by named problems, then a clinician reviews the result in context.
Does a GAD-7 score diagnose anxiety?
No. It is a screening and severity measure. Diagnosis, differential diagnosis, and treatment decisions remain with the responsible clinician.
Can I complete GAD-7 on this page?
No. This is educational catalogue information and a product illustration. Lirena does not provide a public self-test or automated interpretation here.
Is permission required to use GAD-7?
The source form states that no permission is required to reproduce, translate, display, or distribute. Still confirm you are using the official form and that it fits your population and governance.